Population
Cardiac fibroblasts (CFs) isolated from the ventricles of neonatal Sprague-Dawley rats (1-3 days old)
Comparison
Pirfenidone at various concentrations… vs 0 mg/ml pirfenidone (control group)
Design
Preclinical
Follow-up
Up to 72 hours (in vitro)
Authors
Loading...
Supports pirfenidone exploration in myocardial fibrosis; hypothesis-generating in vitro data leave clinical translation open.
Pirfenidone exerts direct pleiotropic antifibrotic effects on cardiac fibroblasts in vitro, supporting its potential use in treating adverse myocardial remodeling.
Shi et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: